Literature DB >> 31496608

Oophorectomy as a Hormonal Ablation Therapy in Metastatic and Recurrent Breast Cancer: Current Indications and Results.

Islam H Metwally1, Omar Hamdy1, Saleh S Elbalka1, Mohamed Elbadrawy1, Dina M Elsaid2.   

Abstract

Breast cancer is the commonest malignancy affecting females. Hormone-positive cancers carry a better prognosis. Many adjuvant and palliative endocrine therapies are in use, including surgical ablation. We retrospectively studied seventy-four patients who did bilateral salpingo-oophorectomy (BSO)/bilateral oophorectomy (BO) for factors affecting survival and prognosis. BSO was superior in overall and progression-free survival. Incidental ovarian metastasis carried a grave prognosis. Surgical hormonal ablation is a viable option with laparoscopic BSO as the approach of choice.

Entities:  

Keywords:  Breast cancer; Hormone therapy; Metastasis; Oophorectomy; Palliation

Year:  2019        PMID： 31496608      PMCID： PMC6708054          DOI： 10.1007/s13193-019-00938-1

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN： 0975-7651


  11 in total

1.  Oophorectomy for breast cancer: history revisited.

Authors:  Richard R Love; John Philips
Journal:  J Natl Cancer Inst       Date:  2002-10-02       Impact factor: 13.506

2.  The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory.

Authors:  Robert J Kurman; Ie-Ming Shih
Journal:  Am J Surg Pathol       Date:  2010-03       Impact factor: 6.394

3.  Adjuvant ovarian suppression in premenopausal breast cancer.

Authors:  Prudence A Francis; Meredith M Regan; Gini F Fleming; István Láng; Eva Ciruelos; Meritxell Bellet; Hervé R Bonnefoi; Miguel A Climent; Gian Antonio Da Prada; Harold J Burstein; Silvana Martino; Nancy E Davidson; Charles E Geyer; Barbara A Walley; Robert Coleman; Pierre Kerbrat; Stefan Buchholz; James N Ingle; Eric P Winer; Manuela Rabaglio-Poretti; Rudolf Maibach; Barbara Ruepp; Anita Giobbie-Hurder; Karen N Price; Marco Colleoni; Giuseppe Viale; Alan S Coates; Aron Goldhirsch; Richard D Gelber
Journal:  N Engl J Med       Date:  2014-12-11       Impact factor: 91.245

4.  Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer.

Authors:  G M Clark; C K Osborne; W L McGuire
Journal:  J Clin Oncol       Date:  1984-10       Impact factor: 44.544

5.  Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study.

Authors:  Noah D Kauff; Susan M Domchek; Tara M Friebel; Mark E Robson; Johanna Lee; Judy E Garber; Claudine Isaacs; D Gareth Evans; Henry Lynch; Rosalind A Eeles; Susan L Neuhausen; Mary B Daly; Ellen Matloff; Joanne L Blum; Paul Sabbatini; Richard R Barakat; Clifford Hudis; Larry Norton; Kenneth Offit; Timothy R Rebbeck
Journal:  J Clin Oncol       Date:  2008-02-11       Impact factor: 44.544

6.  Endocrine Therapy for Hormone Receptor-Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline.

Authors:  Hope S Rugo; R Bryan Rumble; Erin Macrae; Debra L Barton; Hannah Klein Connolly; Maura N Dickler; Lesley Fallowfield; Barbara Fowble; James N Ingle; Mohammad Jahanzeb; Stephen R D Johnston; Larissa A Korde; James L Khatcheressian; Rita S Mehta; Hyman B Muss; Harold J Burstein
Journal:  J Clin Oncol       Date:  2016-05-23       Impact factor: 44.544

7.  Hormone receptors and age distribution in breast cancer patients at a university hospital in northern egypt.

Authors:  Osama Hussein; Mahmoud Mosbah; Omar Farouk; Kamel Farag; Aiman El-Saed; Mohammad Arafa; Ahmed Abdallah
Journal:  Breast Cancer (Auckl)       Date:  2013-06-12

8.  Single-port versus conventional multiport access prophylactic laparoscopic bilateral salpingo-oophorectomy in high-risk patients for ovarian cancer: a comparison of surgical outcomes.

Authors:  Stefano Angioni; Alessandro Pontis; Federica Sedda; Theodoros Zampetoglou; Vito Cela; Liliana Mereu; Pietro Litta
Journal:  Onco Targets Ther       Date:  2015-06-25       Impact factor: 4.147

9.  Cancer incidence in egypt: results of the national population-based cancer registry program.

Authors:  Amal S Ibrahim; Hussein M Khaled; Nabiel Nh Mikhail; Hoda Baraka; Hossam Kamel
Journal:  J Cancer Epidemiol       Date:  2014-09-21

10.  Bilateral Salpingo-oophorectomy Compared to Gonadotropin-Releasing Hormone Agonists in Premenopausal Hormone Receptor-Positive Metastatic Breast Cancer Patients Treated with Aromatase Inhibitors.

Authors:  Koung Jin Suh; Se Hyun Kim; Kyung-Hun Lee; Tae-Yong Kim; Yu Jung Kim; Sae-Won Han; Eunyoung Kang; Eun-Kyu Kim; Kidong Kim; Jae Hong No; Wonshik Han; Dong-Young Noh; Maria Lee; Hee Seung Kim; Seock-Ah Im; Jee Hyun Kim
Journal:  Cancer Res Treat       Date:  2017-02-27       Impact factor: 4.679
View more
  3 in total

1.  Comparison of outcomes in patients with luminal type breast cancer treated with a gonadotropin-releasing hormone analog or bilateral salpingo-oophorectomy: A cohort retrospective study.

Authors:  Dwi Ris Andriyanto; Salman Ardi Syamsu; Muhammad Ihwan Kusuma; Joko Hendarto; Nilam Smaradania; Elridho Sampepajung; Asrul Mappiwali; Muhammad Faruk
Journal:  Ann Med Surg (Lond)       Date:  2022-04-11

2.  Major depressive symptoms in breast cancer patients with ovarian function suppression: a cross-sectional study comparing ovarian ablation and gonadotropin-releasing hormone agonists.

Authors:  Junhan Jiang; Junnan Xu; Li Cai; Li Man; Limin Niu; Juan Hu; Tao Sun; Xinyu Zheng
Journal:  BMC Psychiatry       Date:  2021-12-11       Impact factor: 3.630

Review 3.  Secondary Resistant Mutations to Small Molecule Inhibitors in Cancer Cells.

Authors:  Abdulaziz B Hamid; Ruben C Petreaca
Journal:  Cancers (Basel)       Date:  2020-04-09       Impact factor: 6.639
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.